01513 LIVZON PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.15X | Oper Margin | 24.5% |
|---|---|---|---|
| LT Debt/Equity | 10.7% | Net Margin | 17.5% |
| Total Debt/Equity | 28.4% | Return on Equity | 14.9% |
| Price/Book | 2.35X | Return on Assets | 8.4% |
| (HKD 37.940) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 2,191.98 | 2,153.31 | 2,140.83 | 2,171.84 | 2,035.26 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +1.8 | +0.6 | -1.4 | +6.7 | +39.7 |
| Earnings Per Share (HKD) | 2.382 | 2.318 | 2.29 | 2.322 | 2.174 |
| Earnings Per Share Growth (%) | +2.8 | +1.2 | -1.4 | +6.8 | +39.5 |
| Dividend Per Share (HKD) | 1.199 | 1.482 | 1.744 | 1.512 | 1.506 |
| P/E* (X) | 15.93 | 16.37 | 16.57 | 16.34 | 17.45 |
| Yield (%) | 3.16 | 3.91 | 4.60 | 3.98 | 3.97 |
| Dividend Share (%) | 50.33 | 63.95 | 76.16 | 65.10 | 69.26 |
| Book NAV (HKD) | 16.177 | 16.752 | 16.630 | 16.959 | 15.208 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-06 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 6,272 | 6,282 | -0.2 | 6,690 |
| Operating Result | 1,805 | 1,599 | +12.9 | 1,392 |
| Associates | 28.943 | 13.333 | +117.1 | 37.016 |
| Profit Before Taxation | 1,828 | 1,608 | +13.7 | 1,423 |
| Taxation | 276.889 | 253.695 | +9.1 | 249.299 |
| Profit /( Loss) After Taxation | 1,551 | 1,355 | +14.5 | 1,174 |
| Minority Interests | 270.133 | 183.728 | +47.0 | 39.5 |
| Net Profit | 1,281 | 1,171 | +9.4 | 1,135 |
| Earnings Per Share () | 1.5666 | 1.3640 | +14.9 | 1.3144 |
| Announcement Date | 2025-08-20 | 2024-08-22 | NA | 2023-08-23 |
* Annualised
Last Update Time: 2025-09-06 21:40:25
